porcine heparin
Animal productexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Apr 1, 2010 (NCT01072747)
Timeline
Indications
Mechanism of action
Coagulation factor X/antithrombin III inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- porcine heparin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04490239 | Early Phase 1 (Phase 1) | Oct 9, 2020 | University of Mississippi |
| NCT01072747 | Phase 3 | Apr 1, 2010 | Azidus |
| NCT01072955 | Phase 3 | Apr 1, 2010 | Azidus |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Azidus | For profit | 2 | 2 | 1 | 2010 |
| University of Mississippi | Academic/Hospital | 1 | 1 | 1 | 2020 |
2 organizations
Page 1 / 1